NIDA Clinical Trials Network: Greater New York Node
NIDA 临床试验网络:大纽约节点
基本信息
- 批准号:9814170
- 负责人:
- 金额:$ 22.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-11-02 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAddressAdolescentAdoptedAdoptionAlcoholismAlcoholsAreaBehavior TherapyBudgetsCaribbean regionCaringChargeCitiesClinicalClinical ManagementClinical TrialsClinical Trials NetworkCollaborationsCommunitiesCriminal JusticeDataDevelopmentDiseaseEarly InterventionElectronic Health RecordFosteringFreedomFundingFutureGender IssuesGeneticGenetic ResearchGoalsHIVHIV/HCVHealthHealth PersonnelHealth ServicesHealth Services ResearchHealth systemHealthcare SystemsHepatitis C virusHospitalsIndividualInfectionInfrastructureInstitutionLeadershipLearningLong IslandMainstreamingMedicalMedical InformaticsMedical TechnologyMedicineMental HealthMental disordersMentorshipMethodologyMethodsNational Institute of Drug AbuseNeurosciencesNeurosciences ResearchNew YorkNicotinePatientsPediatricsPharmaceutical PreparationsPharmacotherapyPhasePolicy MakerPopulationPreventionPrimary Health CarePrivate HospitalsProviderPublic HealthPublic HospitalsRegistriesResearchResearch PersonnelResearch TrainingResourcesRisk ReductionScienceServicesSmokingSubstance Use DisorderSubstance abuse problemSystemTechnology TransferTestingTherapeuticTrainingTranslatingUniversitiesVisionaddictionbasebehavioral healthcare coordinationcare outcomescare providerscollegecomparative effectivenesscostdisorder preventioneHealthepidemiology studyexperiencehealth care service organizationhealth care settingshealth information technologyhealth managementimprovedimproved outcomeinnovationmHealthmedical schoolsmedical specialtiesmetropolitanneuroimagingnext generationperformance sitepragmatic trialprogramsscreeningtreatment programtreatment servicestreatment strategyvaccine development
项目摘要
PROJECT SUMMARY/ABSTRACT
The Greater NY Node (GNYN) of the NIDA CTN, under the shared leadership of John Rotrosen and Edward
Nunes, represents the 2010 merger of the New York and Long Island Nodes which have been part of the CTN
since 2000 and 2001 respectively. This third competing renewal application builds on a strong and successful
infrastructure for managing clinical trials and on a track record of innovation and successful implementation of
addictions management in mainstream healthcare settings where the vast majority of SUD patients are seen.
Our vision for the CTN of the future includes (1) a continued focus on integrating management of addiction in
mainstream healthcare settings and management of medical conditions (e.g. HIV, HCV) in addictions settings,
(2) a continued focus on leveraging health information technology which includes using EHRs to coordinate
care and improve outcomes, (3) an evolving focus on studies to inform adaptive treatment strategies and on
relatively low cost registry-based pragmatic comparative effectiveness studies, (4) a continued focus on stage
2 / phase 2 research where CTN resources can be efficiently used to develop new treatments, and (5) a
platform on which focused- and population- level genetics-, clinical neuroscience-, epidemiology- and services-
research and research training can be conducted. The GNYN has 15 years of CTN experience, and the
expertise, resources and partners necessary to support this vision. The team has exceptional breadth and
depth and an established track-record of collaboration both amongst researchers and with providers and
institutions, particularly in the service of the proposed research agenda. The Node has complementary
strengths in integration of addictions management in mainstream healthcare settings; health information
technology, eHealth and mHealth; pharmacotherapy and vaccine development; behavioral therapy and
combined medication-behavioral treatments; HIV, HCV and other infections; co-occurring psychiatric disorders;
prevention, early intervention, pediatrics and adolescents; criminal justice populations; smoking and alcohol;
genetics, clinical neuroscience and neuroimaging; clinical trials methodology; and dissemination,
implementation and sustainability. Healthcare organizations include large public and private hospital-based
systems (Bellevue Hospital Center, NY City Health and Hospitals Corp, Mount Sinai Health System, Einstein
Montefiore Health System, VA NY Harbor Healthcare System and SUNY Upstate University Health System),
all of which have addictions treatment services. Traditional specialty addictions programs include START,
LESC, Odyssey House, Phoenix House and Narco Freedom, which provide a great range of addictions,
medical and behavioral health services and which are keen to coordinate care with mainstream settings. We
continue to engage policy-makers and dissemination experts, including the NY State OASAS, the NY City
DOHMH, the NY City HHC, as well as the NeC-ATTC, and the National Center on Addiction and Substance
Abuse (CASA), so that their input can inform the research agenda and foster adoption of innovation.
项目摘要/摘要
NIDA CTN的大NY节点(GNYN),由John Rotrosen和Edward共同领导
Nunes,代表2010年纽约和长岛节点的合并,这两个节点一直是CTN的一部分
分别自2000年和2001年以来。这第三个竞争性续订申请建立在强大且成功的
管理临床试验的基础设施,以及创新和成功实施
在主流医疗保健环境中的成瘾管理,在那里可以看到绝大多数的SUD患者。
我们对未来CTN的愿景包括:(1)继续专注于将成瘾管理整合到
主流保健设置和成瘾环境中的医疗条件(例如艾滋病毒、丙型肝炎)的管理,
(2)继续注重利用卫生信息技术,包括使用电子健康记录协调
护理和改善结果,(3)不断发展的重点是研究以提供适应性治疗战略和
费用相对较低的基于登记册的务实比较有效性研究,(4)继续侧重于阶段
2/2期研究,其中CTN资源可有效地用于开发新的治疗方法,以及(5)a
专注于-和人口层面的遗传学-临床神经科学-流行病学-和服务的平台
可以进行研究和研究培训。GNYN拥有15年的CTN经验,
支持这一愿景所需的专业知识、资源和合作伙伴。这支球队拥有非凡的广度和
深度和在研究人员之间以及与供应商和
各机构,特别是为拟议研究议程服务的机构。节点具有互补性
在主流医疗保健环境中整合成瘾管理的优势;健康信息
技术、电子健康和移动健康;药物治疗和疫苗开发;行为治疗和
药物-行为联合治疗;艾滋病毒、丙型肝炎和其他感染;共发精神障碍;
预防、早期干预、儿科和青少年;刑事司法人口;吸烟和酗酒;
遗传学、临床神经科学和神经成像;临床试验方法学;以及传播,
实施和可持续性。医疗保健组织包括以大型公立和私立医院为基础的
系统(贝尔维尤医院中心、纽约市卫生和医院公司、西奈山卫生系统、爱因斯坦
Montefiore Health System、VA NY Harbor Healthcare System和SUNY UpState University Health System)、
所有这些都有成瘾治疗服务。传统的专业成瘾项目包括Start,
LESC、奥德赛之家、凤凰屋和纳科自由,它们提供了大量的成瘾,
医疗和行为健康服务,并热衷于将护理与主流环境相协调。我们
继续与政策制定者和传播专家接触,包括纽约州立大学和纽约市
DOHMH,纽约市HHC,以及NEC-ATTC和国家成瘾和物质中心
滥用(CASA),以便他们的投入可以为研究议程提供信息,并促进采用创新。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Edward V. Nunes其他文献
Dissociative identity disorder and substance abuse: the forgotten relationship.
分离性身份障碍和药物滥用:被遗忘的关系。
- DOI:
- 发表时间:
1999 - 期刊:
- 影响因子:2.8
- 作者:
David McDowell;Frances R. Levin;Edward V. Nunes - 通讯作者:
Edward V. Nunes
Anger and depressive states among treatment-seeking drug abusers: testing the psychopharmacological specificity hypothesis.
寻求治疗的药物滥用者的愤怒和抑郁状态:检验精神药理学特异性假设。
- DOI:
- 发表时间:
2001 - 期刊:
- 影响因子:3.7
- 作者:
E. Aharonovich;Hueco T. Nguyen;Edward V. Nunes - 通讯作者:
Edward V. Nunes
The neuropsychological assessment battery (S-NAB) in cocaine-dependent patients
- DOI:
10.1016/j.drugalcdep.2014.02.030 - 发表时间:
2014-07-01 - 期刊:
- 影响因子:
- 作者:
Efrat Aharonovich;Edward V. Nunes;D. Cannizzaro;M. Stohl;Deborah S. Hasin - 通讯作者:
Deborah S. Hasin
New Directions in Medication-Facilitated Behavioral Treatment for Substance Use Disorders
- DOI:
10.1007/s11920-016-0703-4 - 发表时间:
2016-05-25 - 期刊:
- 影响因子:6.700
- 作者:
Elias Dakwar;Edward V. Nunes - 通讯作者:
Edward V. Nunes
Rapid Initiation of Injection Naltrexone for Opioid Use Disorder
快速开始注射纳曲酮治疗阿片类药物使用障碍
- DOI:
10.1001/jamanetworkopen.2024.9744 - 发表时间:
2024 - 期刊:
- 影响因子:13.8
- 作者:
Matisyahu Shulman;Miranda G Greiner;Hiwot M. Tafessu;Onumara Opara;Kaitlyn Ohrtman;Kenzie Potter;Kathryn Hefner;Eve Jelstrom;Richard N Rosenthal;K. Wenzel;Marc Fishman;John Rotrosen;Udi E. Ghitza;Edward V. Nunes;Adam Bisaga - 通讯作者:
Adam Bisaga
Edward V. Nunes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Edward V. Nunes', 18)}}的其他基金
NIDA Clinical Trials Network: New York Node
NIDA 临床试验网络:纽约节点
- 批准号:
10647100 - 财政年份:2022
- 资助金额:
$ 22.96万 - 项目类别:
Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site
使用长效纳曲酮 (4/6) 哥伦比亚方案治疗站点的治疗研究
- 批准号:
7514307 - 财政年份:2008
- 资助金额:
$ 22.96万 - 项目类别:
Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site
使用长效纳曲酮 (4/6) 哥伦比亚方案治疗站点的治疗研究
- 批准号:
8235961 - 财政年份:2008
- 资助金额:
$ 22.96万 - 项目类别:
Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site
使用长效纳曲酮 (4/6) 哥伦比亚方案治疗站点的治疗研究
- 批准号:
8037045 - 财政年份:2008
- 资助金额:
$ 22.96万 - 项目类别:
Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site
使用长效纳曲酮 (4/6) 哥伦比亚方案治疗站点的治疗研究
- 批准号:
8437265 - 财政年份:2008
- 资助金额:
$ 22.96万 - 项目类别:
Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site
使用长效纳曲酮 (4/6) 哥伦比亚方案治疗站点的治疗研究
- 批准号:
7686108 - 财政年份:2008
- 资助金额:
$ 22.96万 - 项目类别:
Drug Abuse Treatment Development and Research Mentoring
药物滥用治疗开发和研究指导
- 批准号:
8069902 - 财政年份:2007
- 资助金额:
$ 22.96万 - 项目类别:
Drug Abuse Treatment Development and Research Mentoring
药物滥用治疗开发和研究指导
- 批准号:
7180794 - 财政年份:2007
- 资助金额:
$ 22.96万 - 项目类别:
Drug Abuse Treatment Development and Research Mentoring
药物滥用治疗开发和研究指导
- 批准号:
8307182 - 财政年份:2007
- 资助金额:
$ 22.96万 - 项目类别:
相似海外基金
Enhancing Structural Competency in School-Based Health Centers to Address LGBTQ+ Adolescent Health Equity
增强校本健康中心的结构能力,以解决 LGBTQ 青少年健康公平问题
- 批准号:
10608426 - 财政年份:2023
- 资助金额:
$ 22.96万 - 项目类别:
Application and feasability of a brief digital screening tool to address parental and adolescent tobacco and electronic cigarette use in pediatric medical care - a pilot study
简短的数字筛查工具的应用和可行性,以解决儿科医疗中父母和青少年烟草和电子烟的使用问题 - 一项试点研究
- 批准号:
486580 - 财政年份:2022
- 资助金额:
$ 22.96万 - 项目类别:
Studentship Programs
Co-design of an intervention to address alcohol use among adolescent boys and young men in Tanzania
共同设计一项干预措施,解决坦桑尼亚青春期男孩和年轻男性的饮酒问题
- 批准号:
MR/V032380/1 - 财政年份:2022
- 资助金额:
$ 22.96万 - 项目类别:
Research Grant
Complex intervention to optimise adolescent BMI pre-conception to address the double burden of malnutrition: A RCT in rural and urban South Africa
优化青少年孕前体重指数以解决营养不良的双重负担的复杂干预措施:南非农村和城市的随机对照试验
- 批准号:
MR/V005790/1 - 财政年份:2021
- 资助金额:
$ 22.96万 - 项目类别:
Research Grant
Application of a brief digital screening tool to address parental and adolescent tobacco and electronic cigarette use in pediatric medical care
应用简短的数字筛查工具来解决儿科医疗中父母和青少年烟草和电子烟的使用问题
- 批准号:
455984 - 财政年份:2021
- 资助金额:
$ 22.96万 - 项目类别:
Operating Grants
Complex intervention to optimise adolescent BMI pre-conception to address the double burden of malnutrition: A RCT in rural and urban South Africa
优化青少年孕前体重指数以解决营养不良的双重负担的复杂干预措施:南非农村和城市的随机对照试验
- 批准号:
MR/V005790/2 - 财政年份:2021
- 资助金额:
$ 22.96万 - 项目类别:
Research Grant
Development of the Cannabis Actions and Practices (CAP): A Parent-Focused Intervention to Address Adolescent Marijuana Use
大麻行动和实践 (CAP) 的发展:以家长为中心的干预措施,解决青少年大麻使用问题
- 批准号:
10057761 - 财政年份:2020
- 资助金额:
$ 22.96万 - 项目类别:
Development of the Cannabis Actions and Practices (CAP): A Parent-Focused Intervention to Address Adolescent Marijuana Use
大麻行动和实践 (CAP) 的发展:以家长为中心的干预措施,解决青少年大麻使用问题
- 批准号:
10213683 - 财政年份:2020
- 资助金额:
$ 22.96万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 22.96万 - 项目类别:
Designing targeted interventions to address HIV vulnerabilities and improve clinical outcomes among conflict affected adolescent girls and young women under 25 in Northern Uganda
设计有针对性的干预措施,以解决乌干达北部受冲突影响的少女和 25 岁以下年轻妇女的艾滋病毒脆弱性并改善临床结果
- 批准号:
356145 - 财政年份:2016
- 资助金额:
$ 22.96万 - 项目类别:
Operating Grants